| Website | dermira.com |
| Category | BioTech |
| Phone | 650-461-4600 |
| info@dermira.com | |
| Employees | |
| Founded | 2010 |
| TOTAL | $42M |
| FUNDING TOTAL | $42M |
| Series A, 10/11 Bay City Capital New Enterprise Associates Canaan Partners | $42M |
Dermira is a development-stage, private biotech company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and owns and licenses a robust pipeline of innovative topical compounds addressing areas of need in dermatology. Our lead product candidate, lemuteporfin (LTS), is currently in clinical trials for acne.
